Christine Siu, CFO and Secretary at Eidos Therapeutics, Inc. (EIDX), sold 20,000 shares at $58.95 ($1.2M) on 2019-12-03, disclosed to the SEC on 2019-12-05.
Open-market sale of $1.2M EIDX by CFO and Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.82 | 600 | $35K | 2.9% |
| 2 | $58.95 | 5,400 | $318K | 27.0% |
| 3 | $59.65 | 4,000 | $239K | 20.2% |
| 4 | $58.60 | 8,800 | $516K | 43.8% |
| 5 | $59.39 | 1,200 | $71K | 6.0% |
| Total | $58.93 avg | 20,000 |
| $1.2M |
| 100% |
| Filing → |
| EIDX | SELL | 2019-07-12 | $197K | — | Filing → |
| EIDX | SELL | 2019-06-07 | $1.0M | — | Filing → |
| EIDX | SELL | 2019-04-26 | $131K | — | Filing → |